Use of recombinant factor VIIa in orthotopic liver transplant.
作者信息
Bhatia Pradeep
机构信息
Department of Anaesthesiology and Critical Care, Dr. SN Medical College, Jodhpur, Rajasthan, India.
出版信息
Indian J Anaesth. 2011 May;55(3):309-10. doi: 10.4103/0019-5049.82651.
Abstract
摘要
相似文献
1
Use of recombinant factor VIIa in orthotopic liver transplant.重组凝血因子VIIa在原位肝移植中的应用。
Indian J Anaesth. 2011 May;55(3):309-10. doi: 10.4103/0019-5049.82651.
2
Use of recombinant factor VIIa during orthotopic liver transplantation.重组凝血因子VIIa在原位肝移植中的应用。
Liver Transpl. 2006 Jul;12(7):1176-7; author reply 1178-9. doi: 10.1002/lt.20710.
3
Factor VIIa administration in orthotopic heart transplant recipients and its impact on thromboembolic events and post-transplant outcomes.在原位心脏移植受者中给予因子 VIIa 及其对血栓栓塞事件和移植后结局的影响。
J Thromb Thrombolysis. 2018 Apr;45(3):452-456. doi: 10.1007/s11239-018-1627-0.
4
Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis.
Blood Coagul Fibrinolysis. 2003 Feb;14(2):169-74. doi: 10.1097/01.mbc.0000046194.72384.99.
5
Recombinant factor VIIa and the surgical patient.重组凝血因子VIIa与外科手术患者
Curr Opin Crit Care. 2006 Aug;12(4):351-6. doi: 10.1097/01.ccx.0000235214.63988.54.
6
Hematologic effects of recombinant factor VIIa combined with hemoglobin-based oxygen carrier-201 for prehospital resuscitation of swine with severe uncontrolled hemorrhage due to liver injury.重组凝血因子VIIa联合血红蛋白氧载体-201对肝损伤致严重失控性出血猪进行院前复苏的血液学效应
Blood Coagul Fibrinolysis. 2008 Oct;19(7):669-77. doi: 10.1097/MBC.0b013e3283089198.
7
Pediatric off-label use of recombinant factor VIIa.重组凝血因子VIIa在儿科的超说明书用药
Pediatrics. 2009 Mar;123(3):1066-72. doi: 10.1542/peds.2008-1685.
8
Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study.
Transplantation. 2001 Feb 15;71(3):402-5. doi: 10.1097/00007890-200102150-00011.
9
Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores.重组凝血因子VIIa可降低终末期肝病模型（MELD）评分高的肝移植患者的输血需求。
Transfus Med. 2006 Apr;16(2):93-100. doi: 10.1111/j.1365-3148.2006.00653.x.
10
Recombinant factor VIIa for life-threatening bleeding in high-risk cardiac surgery despite full-dose aprotinin.尽管使用了全剂量抑肽酶，重组凝血因子VIIa仍用于高危心脏手术中威胁生命的出血情况。
Anesth Analg. 2004 Jul;99(1):27-30. doi: 10.1213/01.ANE.0000117582.66492.89.
引用本文的文献
1
Authors' reply.作者回复。
Indian J Anaesth. 2011 May;55(3):310-1.
本文引用的文献
1
Antifibrinolytics in liver surgery.肝脏手术中的抗纤溶药物
Indian J Anaesth. 2010 Nov;54(6):489-95. doi: 10.4103/0019-5049.72636.
2
Recombinant activated factor VII in critical bleeding after orthotopic liver transplantation.重组活化凝血因子VII用于原位肝移植术后严重出血
Transplant Proc. 2008 Jul-Aug;40(6):1989-90. doi: 10.1016/j.transproceed.2008.05.021.
3
Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation.围手术期重复剂量重组凝血因子VIIa在肝移植中的疗效和安全性
Liver Transpl. 2005 Aug;11(8):973-9. doi: 10.1002/lt.20470.
4
Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease.慢性肝病肝移植中单次推注重组凝血因子VIIa的安全性和有效性
Liver Transpl. 2005 Aug;11(8):895-900. doi: 10.1002/lt.20458.
5
Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study.
Transplantation. 2001 Feb 15;71(3):402-5. doi: 10.1097/00007890-200102150-00011.
Zotero 插件